Blocking one receptor calms aging kidney immune cells
As kidneys age, senescent immune cells accumulate and damage tissue. Blocking a single protein on the surface of those cells appears to reverse that process, at least in mice.
Macrophages are immune cells that patrol and repair tissues. In aging kidneys, they increasingly enter a state of cellular senescence: they stop dividing but keep sending out inflammatory signals. Those sustained signals damage kidney tissue and accelerate the decline of kidney function.
The role of the P2RX7 receptor
Researchers found that macrophages progressively accumulate more of the P2RX7 receptor on their surface as they move toward senescence in the kidney. They used single-cell gene activity analyses to map this progression. They then tested a small molecule that blocks this receptor.
The result: the researchers observed reduced macrophage senescence, improved kidney function, and less tissue damage. This applied both in mice with kidney injury from sepsis and in naturally aging mice. Cells with the blocked receptor also showed better wound healing and migration capacity.
What does this mean for kidney aging?
This is animal research. Whether the mechanism works the same way in humans has not been established. The findings were published in the International Journal of Biological Sciences and are preliminary, but the target is specific: one receptor on one cell type in one organ. That makes it feasible to test in follow-up studies.
For broader longevity research, the study is also notable because it demonstrates that senescence of immune cells, not just structural tissue cells, directly contributes to organ aging. Calming or clearing those immune cells may represent a separate route alongside targeting senescent tissue cells.
Search terms to explore further: macrophage senescence kidney aging, purinergic receptor P2RX7 immune cell, immune senescence organ function